Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	7.88	11.69	10.83
Graham Fair Price	65.15	48084.53	29116.01
PEG	-83.64	0.04	-0.22
Price/Book	5.24	0.27	0.26
Price/Cash Flow	-89.10	10.67	-97.82
Prices/Earnings	-60.45	6.02	15.23
Price/Sales	-10.52	0.95	1.07
Price/FCF	-89.10	10.67	-97.82
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	28.08	0.17	0.13
Operating Margin	112.33	0.07	0.03
ROA	164.20	< 0.005	< 0.005
ROE	< 0.005	0.01	166.09
ROIC	< 0.005	0.01	195.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.01	-0.09	87.71
Dividends QOQ	0.00	8.89	100.00
EBIT QOQ	-0.32	1.53	377.72
EPS QOQ	-0.70	1.69	141.73
FCF QOQ	-1.19	10.77	805.28
Revenue QOQ	-0.07	0.19	188.59
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.90	58.55	-9.77
Days Sales Outstanding (DSO)	84.51	74.82	-11.46
Inventory Turnover	1.39	1.54	10.83
Debt/Capitalization	0.16	0.16	-2.26
Quick Ratio	1.07	1.09	2.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	93885.74	108013.56	15.05
Cash	13663.98	15284.45	11.86
Capex	-847.30	900.05	6.23
Free Cash Flow	-249.96	2442.44	877.14
Revenue	22916.91	27287.74	19.07
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.50	1.52	0.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.85	2.37	-17.09
Naive Interpretation	Member

06 - Financial Health · Weak

Rating